Debra Schwab Brandt, DO

Clinician in Medicine (Medical Oncology)

Patient Care

Accepts new patients? Yes
Patient Type:
Referrals: Not Applicable

Patient Care Organizations

Cancer Center, Yale

Medical Oncology

Yale Medical Group

Board Certifications

  • Internal Medicine AB of Internal Medicine (1995)

  • Hematology (Internal Medicine) AB of Internal Medicine (1999)

  • Medical Oncology AB of Internal Medicine (1998)

Clinical Trials

Conditions Study Title
Lung A randomized phase II trial of combination versus single agent chemotherapy in high-risk elderly pat
Multiple Myeloma SHIVERING 2 Trial
Other Digestive Organ, Pancreas E2211: Phase II study of Temozolomide or Temozolomide + Capecitabine in Patients w Pancreatic Tumors
Multiple Myeloma Bortezomib,Dexamethasone, Lenalidomide w/o Elotuzumab for Newly Diagnosed High Risk Multiple Myeloma
Pancreas Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)
Breast - Female, Breast - Male Olaparib as Adjuvant Treatment in Patients With BRCA Mutated High Risk HER2 Negative breast cancer
Lung S1403
Lung PINNACLE: Phase 1b/2 Study of Anti-Notch Antibody Therapy with Cisplatin and Etoposide in SCLC
Colon, Rectum Phase III study of Nintedanib plus BSC vs placebo plus BSC in pts with refractory colorectal cancer
Leukemia, other Randomized Phase III: BR vs Ibrutinib +R vs Ibrutinib Alone in Untreated Older Pts with CLL
Lung Safety and Efficacy of Abraxane Maintenance post Abraxane + Carboplatin in squamous cell lung cancer
Lung Biomarker-Driven Master Protocol for Squamous Cell Lung Cancer
Breast - Female Neoadj ph 2 AI plus everolimus in postmenopausal women w/ ER pos/HER2 neg, low risk score
Lymphoid Leukemia Ibrutinib+Rituximab v. Fludarabine Phosphate, Cyclophosphamide, and Rituximab in untreated CLL
Pancreas S1313: Phase Ib/II Study of mFOLFIRINOX +PEGPH20 vs. mFOLFIRINOX in Met. Pancreatic Adenocarcinoma
Leukemia, other E1910: Blinatumomab for Frontline BCR-ABL (-) B Cell ALL
Breast - Female, Breast - Male Phase II with Orteronel as Monotherapy for Metastatic Breast Cancer that expresses Androgen Receptor
Breast - Female, Breast - Male S1207 Phase 3 Rand, Adj Endocrine Tx plus Everolimus in High risk ER/PR + HER2neg BC
Breast - Female Neo-Adj, Phase 2, Pertuzumab and Trastuzumab with weekly Paclitaxel and FEC, HER2-pos Breast Cancer
Colon Phase II Study of KD018 as Modulator of Irinotecan in Patients with Metastatic Colorectal Cancer

Edit this profile

Contact Info

Debra Schwab Brandt, DO
Patient Care Location
Smilow Cancer Care - Torrington
200 Kennedy Drive

Torrington, CT 06790
View on map...
Mailing Address
PO Box 208028
New Haven, CT 06520-8028